BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 2005;29:903-11. [PMID: 15958855 DOI: 10.1097/01.pas.0000157997.61177.08] [Cited by in Crossref: 112] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Ranganathan S. Histiocytic proliferations. Seminars in Diagnostic Pathology 2016;33:396-409. [DOI: 10.1053/j.semdp.2016.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
2 Chadburn A. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8). Seminars in Diagnostic Pathology 2013;30:113-29. [DOI: 10.1053/j.semdp.2012.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Goode E, Smith JA, Gilpatrick M, Matney C, Borch-Christensen B, Henry MM. Autoimmune lymphoproliferative syndrome with Langerhans cell histiocytosis diagnosis. Pediatr Blood Cancer 2021;:e29301. [PMID: 34398530 DOI: 10.1002/pbc.29301] [Reference Citation Analysis]
4 Kim YJ, Dale JK, Noel P, Brown MR, Nutman TB, Straus SE, Klion AD. Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome. Am J Hematol 2007;82:615-24. [PMID: 17266055 DOI: 10.1002/ajh.20851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
5 Fu WJ, Du J, Lu J, Wang LZ, Yang JM, He MX, Hu XX. [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases]. Zhonghua Xue Ye Xue Za Zhi 2019;40:656-61. [PMID: 31495132 DOI: 10.3760/cma.j.issn.0253-2727.2019.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Emile JF, Charlotte F, Chassagne-Clement C, Copin MC, Fraitag S, Mokhtari K, Moreau A. [Histiocytoses: General classification and molecular criteria]. Presse Med 2017;46:46-54. [PMID: 26952138 DOI: 10.1016/j.lpm.2016.01.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
7 Jia J, Tian Q, Zhang H, Zheng Y. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body. Int J Dermatol 2017;56:576-8. [DOI: 10.1111/ijd.13574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr 2013;25:722-9. [PMID: 24240292 DOI: 10.1097/MOP.0000000000000032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
9 Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders. Curr Oncol Rep. 2019;21:62. [PMID: 31115724 DOI: 10.1007/s11912-019-0810-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
10 Joshi SS, Joshi S, Muzumdar G, Turel KE, Shah RM, Ammbulkar I, Hussain MM, Choudhari KA. Cranio-spinal Rosai Dorfman disease: case series and literature review. Br J Neurosurg 2019;33:176-83. [PMID: 28532172 DOI: 10.1080/02688697.2017.1329517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
11 Tzankov A. [Non-neoplastic lesions of the mediastinum]. Pathologe 2016;37:400-11. [PMID: 27465275 DOI: 10.1007/s00292-016-0197-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Su HC, Lenardo MJ. Genetic defects of apoptosis and primary immunodeficiency. Immunol Allergy Clin North Am 2008;28:329-51, ix. [PMID: 18424336 DOI: 10.1016/j.iac.2008.01.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
13 Bi Y, Huo Z, Meng Y, Wu H, Yan J, Zhou Y, Liu X, Song L, Lu Z. Extranodal Rosai-Dorfman disease involving the right atrium in a 60-year-old male. Diagn Pathol 2014;9:115. [PMID: 24916611 DOI: 10.1186/1746-1596-9-115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y. Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol 2017;147:204-16. [PMID: 28395106 DOI: 10.1093/ajcp/aqw215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
15 Ben Turkia H, Ben Romdhane M, Azzouz H, Ben Chehida A, Slim Abdelmoula M, Benabdelaziz R, Tebib N, Ben Messaoud M, Sahtout S, Chelly I, Zitouna M, Mnif E, Ben Dridi MF. [Rosai-Dorfman disease: therapeutic issues in 2 cases]. Arch Pediatr 2011;18:1205-9. [PMID: 21992893 DOI: 10.1016/j.arcped.2011.08.008] [Reference Citation Analysis]
16 Boggio E, Melensi M, Bocca S, Chiocchetti A, Comi C, Clemente N, Orilieri E, Soluri MF, D'Alfonso S, Mechelli R, Gentile G, Poggi A, Salvetti M, Ramenghi U, Dianzani U. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function. Hum Immunol 2012;73:585-92. [PMID: 22425739 DOI: 10.1016/j.humimm.2012.02.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Congyang L, Xinggui W, Hao L, Weihua H. Synchronous histiocytic sarcoma and diffuse large B cell lymphoma involving the stomach: a case report and review of the literature. Int J Hematol. 2011;93:247-252. [PMID: 21286876 DOI: 10.1007/s12185-011-0773-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
18 Andrès E, Viallard JF. ["Atypical" or "orphan" cellular proliferations: current data and perspectives]. Presse Med 2007;36:1653-4. [PMID: 17628390 DOI: 10.1016/j.lpm.2007.06.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Tzankov A, Dirnhofer S. A pattern-based approach to reactive lymphadenopathies. Semin Diagn Pathol 2018;35:4-19. [PMID: 28619469 DOI: 10.1053/j.semdp.2017.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
20 Cooper SL, Arceci RJ, Gamper CJ, Teachey DT, Schafer ES. Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus. Pediatr Blood Cancer 2016;63:358-60. [PMID: 26452062 DOI: 10.1002/pbc.25770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
21 Kim YJ, Lee KH, Lee WJ, Won CH, Chang SE, Choi JH, Lee MW. Cutaneous Rosai-Dorfman disease and annular elastolytic giant cell granuloma successively appearing in a case. J Dermatol 2019;46:e470-2. [PMID: 31392739 DOI: 10.1111/1346-8138.15044] [Reference Citation Analysis]
22 Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges]. Rev Med Interne 2018;39:635-40. [PMID: 29501513 DOI: 10.1016/j.revmed.2018.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Haroche J, Abla O. Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease. Hematology 2015;2015:571-8. [DOI: 10.1182/asheducation.v2015.1.571.3916289] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
24 Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131:2877-2890. [PMID: 29720485 DOI: 10.1182/blood-2018-03-839753] [Cited by in Crossref: 124] [Cited by in F6Publishing: 103] [Article Influence: 31.0] [Reference Citation Analysis]
25 Jeffreys SM, Levy RA, Crary SE. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder. Journal of Pediatric Hematology/Oncology 2018;40:e305-8. [DOI: 10.1097/mph.0000000000000981] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Fayne R, Rengifo SS, Gonzalez I, Solorzano JL, Gonzalez D, Vega F, Cho-Vega JH. Primary cutaneous Rosai-Dorfman disease; a case-based review of a diagnostically and therapeutically challenging rare variant. Ann Diagn Pathol 2020;45:151446. [PMID: 31978810 DOI: 10.1016/j.anndiagpath.2019.151446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Chisolm SS, Schulman JM, Fox LP. Adult Xanthogranuloma, Reticulohistiocytosis, and Rosai-Dorfman Disease. Dermatologic Clinics 2015;33:465-73. [DOI: 10.1016/j.det.2015.03.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
28 Piris MA, Aguirregoicoa E, Montes-moreno S, Celeiro-muñoz C. Castleman Disease and Rosai-Dorfman Disease. Seminars in Diagnostic Pathology 2018;35:44-53. [DOI: 10.1053/j.semdp.2017.11.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
29 Pagel JM, Lionberger J, Gopal AK, Sabath DE, Loeb K. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol 2007;82:1121-2. [PMID: 17696200 DOI: 10.1002/ajh.21024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
30 Kalakutskiy NV, Baranova IB, Ovsepian TN, Ribakova MG, Kasimova ND. [Non-Langengars type of sinus histiocytosis with maxillofacial skin lesions (Rosai-Dorfman disease). Clinical case description]. Stomatologiia (Mosk) 2021;100:90-5. [PMID: 34180631 DOI: 10.17116/stomat202110003190] [Reference Citation Analysis]
31 Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood 2011;118:5741-51. [PMID: 21885601 DOI: 10.1182/blood-2011-07-325217] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 9.8] [Reference Citation Analysis]
32 Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol. 2020;73:697-705. [PMID: 32591351 DOI: 10.1136/jclinpath-2020-206733] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
33 Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Rosenwald A, Wotherspoon A, Fend F. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch 2017;471:467-89. [PMID: 28695297 DOI: 10.1007/s00428-017-2176-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
34 Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672-2681. [PMID: 26966089 DOI: 10.1182/blood-2016-01-690636] [Cited by in Crossref: 533] [Cited by in F6Publishing: 448] [Article Influence: 88.8] [Reference Citation Analysis]
35 Rezk SA, Sullivan JL, Woda BA. Nonneoplastic Histiocytic Proliferations of Lymph Nodes and Bone Marrow. Hematopathology. Elsevier; 2011. pp. 801-10. [DOI: 10.1016/b978-0-7216-0040-6.00051-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Karakuş V, Dere YM, Soysal DE. Long-Lasting Follow-Up with Low-Dose Steroid in an 18-Year-Old Male with Rosai-Dorfman Disease. Case Rep Med 2020;2020:5727569. [PMID: 32180809 DOI: 10.1155/2020/5727569] [Reference Citation Analysis]
37 Bonzheim I, Geissinger E, Chuang WY, Roth S, Ströbel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Müller-Hermelink HK, Rüdiger T. Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. J Hematop 2008;1:11-21. [PMID: 19669200 DOI: 10.1007/s12308-008-0003-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
38 Emile JF, Cohen-Aubart F, Collin M, Fraitag S, Idbaih A, Abdel-Wahab O, Rollins BJ, Donadieu J, Haroche J. Histiocytosis. Lancet 2021;398:157-70. [PMID: 33901419 DOI: 10.1016/S0140-6736(21)00311-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Galicier L, Fieschi C, Meignin V, Clauvel J, Oksenhendler É. Histiocytose sinusale de Rosai-Dorfman. La Presse Médicale 2007;36:1669-75. [DOI: 10.1016/j.lpm.2007.06.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
40 George LA, Teachey DT. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children. Pediatr Drugs 2016;18:261-72. [DOI: 10.1007/s40272-016-0175-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
41 Yang X, Fang C, Sha Y, Li Q, Zhang X, Du F, Tian W. An extremely rare case of Rosai-Dorfman disease in the spleen. BMC Surg 2021;21:24. [PMID: 33407333 DOI: 10.1186/s12893-020-01014-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Long E, Lassalle S, Cheikh-Rouhou R, Hofman V, Lacour JP, Hofman P. Intestinal occlusion caused by Rosai-Dorfman disease mimicking colonic diverticulitis. Pathol Res Pract 2007;203:233-7. [PMID: 17400399 DOI: 10.1016/j.prp.2007.01.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
43 Koneti Rao V, Straus SE. Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology 2013;11:15-23. [DOI: 10.1080/10245330500329094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
44 Picarsic J, Jaffe R. Nosology and Pathology of Langerhans Cell Histiocytosis. Hematology/Oncology Clinics of North America 2015;29:799-823. [DOI: 10.1016/j.hoc.2015.06.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
45 Golwala ZM, Taur P, Pandrowala A, Chandak S, Desai M. Sirolimus-A targeted therapy for Rosai-Dorfman disease. Pediatr Blood Cancer 2019;66:e27994. [PMID: 31524314 DOI: 10.1002/pbc.27994] [Reference Citation Analysis]
46 Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, Vaglio A, Abdel-Wahab O, Emile JF, Amoura Z. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol 2017;18:e113-25. [PMID: 28214412 DOI: 10.1016/S1470-2045(17)30031-1] [Cited by in Crossref: 104] [Cited by in F6Publishing: 46] [Article Influence: 20.8] [Reference Citation Analysis]
47 Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematology Am Soc Hematol Educ Program 2015;2015:571-8. [PMID: 26637774 DOI: 10.1182/asheducation-2015.1.571] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
48 Tzankov A, Kremer M, Leguit R, Orazi A, van der Walt J, Gianelli U, Hebeda KM. Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Ann Hematol 2018;97:2117-28. [PMID: 30084011 DOI: 10.1007/s00277-018-3436-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
49 Huang Q, Chang KL, Weiss LM. Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. Am J Surg Pathol 2006;30:1189-92. [PMID: 16931965 DOI: 10.1097/01.pas.0000209846.52046.62] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
50 Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance. Autoimmun Rev 2010;9:488-93. [PMID: 20170754 DOI: 10.1016/j.autrev.2010.02.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
51 McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. Histiocytic disorders. Nat Rev Dis Primers 2021;7:73. [PMID: 34620874 DOI: 10.1038/s41572-021-00307-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Venkataraman G, McClain KL, Pittaluga S, Rao VK, Jaffe ES. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol 2010;34:589-94. [PMID: 20216376 DOI: 10.1097/PAS.0b013e3181d5ddf8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
53 Ajise OE, Stahl-Herz J, Goozner B, Cassai N, McRae G, Wieczorek R. Extranodal Rosai-Dorfman disease arising in the right atrium: a case report with literature review. Int J Surg Pathol 2011;19:637-42. [PMID: 21632641 DOI: 10.1177/1066896911409577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
54 Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 2014;123:1989-99. [PMID: 24398331 DOI: 10.1182/blood-2013-10-535393] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 16.6] [Reference Citation Analysis]
55 Di Tommaso L, Rahal D, Bossi P, Roncalli M. Hepatic rosai-dorfman disease with coincidental lymphoma: report of a case. Int J Surg Pathol 2010;18:540-3. [PMID: 19117970 DOI: 10.1177/1066896908329590] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
56 Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders: Histiocytic Disorders Review. Pediatr Blood Cancer 2014;61:1329-35. [DOI: 10.1002/pbc.25017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
57 Kroft SH. Rosai-Dorfman disease: Familiar yet enigmatic. Semin Diagn Pathol 2016;33:244-53. [PMID: 27370529 DOI: 10.1053/j.semdp.2016.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
58 Hirt MB, Heskett J, Veerula V, Warren S, Avashia-Khemka N, Mark LA. Multifocal Rosai-Dorfman disease with involvement of the pinna. JAAD Case Rep 2017;3:233-5. [PMID: 28443319 DOI: 10.1016/j.jdcr.2017.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 de Souza Maciel Rocha Horvat N, Coelho CR, Roza LC, de Souza RC, Costa YB, de Oliveira EC, de Souza Rocha M, Baroni RH. Spectrum of abdominal imaging findings in histiocytic disorders. Abdom Imaging 2015;40:2738-46. [PMID: 25985969 DOI: 10.1007/s00261-015-0449-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
60 Picarsic J, Jaffe R. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders. In: Abla O, Janka G, editors. Histiocytic Disorders. Cham: Springer International Publishing; 2018. pp. 3-50. [DOI: 10.1007/978-3-319-59632-7_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Hsiao CH, Tsai TF, Yang TH, Liu CM. Clinicopathologic characteristics of Rosai-Dorfman disease in a medical center in northern taiwan. J Formos Med Assoc. 2006;105:701-707. [PMID: 16959617 DOI: 10.1016/s0929-6646(09)60197-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
62 Tatit RT, Raffa PEAZ, de Almeida Motta GC, Bocchi AA, Guimaraes JL, Franceschini PR, de Aguiar PHP. Rosai-Dorfman disease mimicking images of meningiomas: Two case reports and literature review. Surg Neurol Int 2021;12:292. [PMID: 34221623 DOI: 10.25259/SNI_918_2020] [Reference Citation Analysis]
63 Facchetti F, Lonardi S, Vermi W, Lorenzi L. Updates in histiocytic and dendritic cell proliferations and neoplasms. Diagnostic Histopathology 2019;25:217-28. [DOI: 10.1016/j.mpdhp.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
64 Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica 2017;102:364-72. [PMID: 27846610 DOI: 10.3324/haematol.2015.138081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
65 Doglioni C. Rosai-Dorfman disease. A legacy of Professor Rosai that is still not exploited completely. Pathologica 2021;113:388-95. [PMID: 34837097 DOI: 10.32074/1591-951X-548] [Reference Citation Analysis]
66 Worth A, Thrasher AJ, Gaspar HB. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 2006;133:124-40. [PMID: 16611303 DOI: 10.1111/j.1365-2141.2006.05993.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 7.1] [Reference Citation Analysis]
67 Müllauer L, Emhofer J, Wohlfart S, Pichlhöfer B, Stary S, Ebetsberger G, Mannhalter C, Chott A. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis. Am J Surg Pathol 2008;32:329-34. [PMID: 18223337 DOI: 10.1097/PAS.0b013e3181484f6d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology 2014;64:455-9. [PMID: 24215263 DOI: 10.1111/his.12274] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
69 Galicier L, Boutboul D, Oksenhendler É, Fieschi C, Meignin V. Histiocytose sinusale de Rosai–Dorfman. La Presse Médicale 2017;46:107-16. [DOI: 10.1016/j.lpm.2016.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
70 Kumar B, Karki S, Paudyal P. Diagnosis of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) by fine needle aspiration cytology. Diagn Cytopathol 2008;36:691-5. [DOI: 10.1002/dc.20904] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
71 Hartenstine J, Jackson H, Mortman K. A 38-Year-Old Woman With an Osteolytic Rib Lesion. Chest 2016;149:e79-85. [PMID: 26965978 DOI: 10.1016/j.chest.2015.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Chan JK, Kwong Y. Common misdiagnoses in lymphomas and avoidance strategies. The Lancet Oncology 2010;11:579-88. [DOI: 10.1016/s1470-2045(09)70351-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
73 Suryaprakash S, George A, Langenburg S, Savaşan S. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations. Ann Hematol 2020;99:2965-7. [PMID: 32944792 DOI: 10.1007/s00277-020-04264-3] [Reference Citation Analysis]
74 Gualco G, van den Berg A, Koopmans S, Bacchi LM, Carneiro SS, Ruiz E, Vecchi AP, Chan JK. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene. Human Pathology 2008;39:137-41. [DOI: 10.1016/j.humpath.2007.07.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
75 Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood 2010;115:5164-9. [PMID: 20360470 DOI: 10.1182/blood-2010-01-263145] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 6.8] [Reference Citation Analysis]
76 Garza-Guajardo R, García-Labastida LE, Rodríguez-Sánchez IP, Gómez-Macías GS, Delgado-Enciso I, Chaparro MM, Barboza-Quintana O. Cytological diagnosis of Rosai-Dorfman disease: A case report and revision of the literature. Biomed Rep 2017;6:27-31. [PMID: 28123703 DOI: 10.3892/br.2016.814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
77 Potts CA, Bozeman AP, Walker AN, Floyd WE. Cutaneous Rosai–Dorfman Disease of the Forearm: Case Report. The Journal of Hand Surgery 2008;33:1409-13. [DOI: 10.1016/j.jhsa.2008.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
78 Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr 2012;24:1-8. [PMID: 22157362 DOI: 10.1097/MOP.0b013e32834ea739] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
79 Garrido Colino C. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome]. An Pediatr (Barc) 2014;80:122.e1-7. [PMID: 24055319 DOI: 10.1016/j.anpedi.2013.06.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]